Clinical trial / 2005
A two-year soy food intervention did not significantly change circulating IGF-1 or IGFBP-3 levels in healthy premenopausal women.
In a 2-year randomized trial, 196 healthy premenopausal women consumed either two daily servings of soya foods (tofu, soya milk, soya nuts, or soya protein powder providing 50 mg isoflavones and 5-22 g soya protein per serving) or maintained their regular diet. Morning serum samples were collected at baseline, 3, 6, 12, and 24 months during the luteal phase. Researchers found no significant intervention effect on IGF-1, IGFBP-3, or their molar ratio across the entire study period. However, urinary isoflavone excretion during the study period was positively associated with IGF-1 (P=0.04) and the IGF-1:IGFBP-3 ratio (P=0.06).
- Study type
- 2-year randomized nutritional trial
- Who was studied
- 196 healthy premenopausal women
- What was measured
- Circulating IGF-1, IGFBP-3 levels, and their molar ratio
THE PAPER
Insulin-like growth factor-1 and binding protein-3 in a 2-year soya intervention among premenopausal women.
Maskarinec G, Takata Y, Murphy SP, Franke AA, Kaaks R. Br J Nutr, 2005.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.